Clinical Evidence

A Structured Approach to Non-Invasive Satiety Modulation

GASTER control® is developed within a structured clinical and scientific framework aimed at evaluating non-invasive biomechanical approaches to supporting the perception of satiety signals.

The development strategy combines physiological rationale, real-world observations, and progressive clinical evaluation.

Scientific Rationale

A Mechanical Component of Satiety

Satiety is a complex physiological process involving:

mechanical signals (gastric distension)
neuro-hormonal regulation

In some individuals, the perception of these signals may be altered, contributing to difficulties in regulating food intake.

GASTER control® is designed to act on the mechanical component through controlled external abdominal compression, with the objective of modulating the conditions under which satiety is perceived.

This approach does not induce satiety directly,
but supports its perception within physiological processes.

Exploratory Observations

Real-World Use and Early Insights

Preliminary observational data collected in real-life conditions suggest consistent trends associated with the use of devices integrating GASTER control® technology:

facilitation of satiety perception during meals
reduction in food intake and portion size
improvement in eating behavior regulation
progressive weight reduction in many users
good overall tolerance and usability

These observations are:

exploratory in nature
derived from real-world use
consistent with the proposed biomechanical mechanism

They provide initial insights into the potential role of external mechanical modulation in eating behavior support.

Clinical Development

Ongoing Evaluation and Structured Research

GASTER control® is currently undergoing progressive clinical evaluation in collaboration with healthcare professionals, including bariatric specialists.

Development activities include:

real-world observational data collection
integration into clinical practice settings
participation in structured observational registries
preparation of controlled clinical studies

A multicentric study is in development to further assess:

clinical outcomes
patient selection
integration into care pathways

Interpretation of Current Data

Early-Stage but Consistent Signals

The current level of evidence reflects an early stage of clinical development.

Findings should be interpreted as:

indicative trends
hypothesis-generating observations
requiring confirmation through controlled studies

This approach is aligned with a progressive and rigorous clinical development strategy.

Position Within Medical Research

GASTER control® is positioned within an emerging field of research exploring:

non-invasive modulation of physiological signals
integration of biomechanical approaches into metabolic health
support of eating behavior regulation through external mechanisms

This positioning reflects a growing interest in complementary, non-pharmacological strategies.

Commitment to Scientific Rigor

GASTER control® is committed to:

transparent communication of data
alignment with medical and regulatory standards
collaboration with healthcare professionals
progressive validation through structured research

Scientific development is conducted with the objective of ensuring clinical relevance, safety, and reproducibility.

Summary

GASTER control® is being developed as a non-invasive biomechanical approach aimed at supporting the perception of satiety signals.

Early observational data suggest consistent behavioral effects,
currently under further evaluation through structured clinical development programs.